Key Points
- Insider sale: Janet Liang sold 7,338 shares at an average $16.59 on Dec. 2, reducing her stake by 4.08% to 172,527 shares (worth about $2.86M) and raising $121,737.42.
- Recent results and stock moves: Oscar reported ($0.53) EPS beating estimates by $0.02 but missed revenue at $2.93B (up 23.2% YoY); the stock traded around $17.12, within a 1‑year range of $11.20–$23.80.
- Analyst/institutional view: MarketBeat shows an average rating of "Reduce" with a $14.86 target, while institutions own about 75.7% of shares and several funds notably increased holdings.
Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Adam Mcananey sold 1,852 shares of Oscar Health stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total transaction of $30,724.68. Following the transaction, the insider directly owned 179,241 shares of the company's stock, valued at approximately $2,973,608.19. This trade represents a 1.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Oscar Health Stock Down 0.2%
NYSE:OSCR traded down $0.03 during mid-day trading on Friday, hitting $17.15. 706,952 shares of the company's stock were exchanged, compared to its average volume of 14,530,396. The company has a market cap of $4.54 billion, a PE ratio of -15.32 and a beta of 1.88. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.80. The business has a fifty day moving average price of $18.06 and a 200 day moving average price of $16.94.
Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The firm had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. During the same period last year, the business earned ($0.22) earnings per share. The business's revenue was up 23.2% on a year-over-year basis. Equities analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.
Analysts Set New Price Targets
Several equities research analysts have commented on the company. Weiss Ratings reissued a "sell (d)" rating on shares of Oscar Health in a report on Wednesday, October 8th. Piper Sandler raised Oscar Health from a "neutral" rating to an "overweight" rating and lifted their price target for the stock from $13.00 to $25.00 in a research report on Tuesday, November 25th. Zacks Research raised shares of Oscar Health from a "strong sell" rating to a "hold" rating in a research report on Monday, October 13th. Wells Fargo & Company reduced their price objective on shares of Oscar Health from $14.00 to $11.00 and set an "underweight" rating for the company in a research note on Thursday, November 13th. Finally, Barclays upped their target price on shares of Oscar Health from $11.00 to $13.00 and gave the stock an "underweight" rating in a research note on Monday, November 10th. One investment analyst has rated the stock with a Buy rating, five have given a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, Oscar Health currently has an average rating of "Reduce" and a consensus target price of $14.86.
View Our Latest Analysis on Oscar Health
Hedge Funds Weigh In On Oscar Health
A number of hedge funds have recently bought and sold shares of the business. American Century Companies Inc. lifted its stake in Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock valued at $100,298,000 after acquiring an additional 2,495,691 shares during the period. Nuveen LLC purchased a new position in shares of Oscar Health during the first quarter valued at approximately $29,684,000. Farallon Capital Management LLC lifted its position in Oscar Health by 146.5% during the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock valued at $68,886,000 after purchasing an additional 2,163,000 shares during the period. Thrive Capital Management LLC boosted its holdings in Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Finally, State of Michigan Retirement System bought a new stake in Oscar Health in the 3rd quarter worth approximately $27,448,000. Hedge funds and other institutional investors own 75.70% of the company's stock.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
